期刊文献+

Synthesis and Crystal Structure of exo-4-(3,4-Dichlorophenyl)-8-ethyl-3,3a,4,5,8, 12d-hexahydro-2H-furo[3,2-c]indolo[3,2-f]quinoline

Synthesis and Crystal Structure of exo-4-(3,4-Dichlorophenyl)-8-ethyl-3,3a,4,5,8, 12d-hexahydro-2H-furo[3,2-c]indolo[3,2-f]quinoline
在线阅读 下载PDF
导出
摘要 The title compound exo-4-(3,4-dichlorophenyl)-8-ethyl-3,3a,4,5,8,12d-hexahydro-2H-furo[3,2-c]indolo[3,2-f]quinoline (C25H22Cl2N2O, Mr = 437.35) was synthesized and crystallized. The crystal belongs to tetragonal, space group I4(1)/a with a = 17.4903(3), b = 17.4903(3), c = 28.3403(5) , Z = 16, V = 8669.6(3) 3, Dc = 1.340 g·cm-3, μ(MoKɑ) = 0.319 mm-1, F(000) = 3648, R = 0.0429 and wR = 0.711 for 2714 observed reflections I 2σ(I). X-ray analysis reveals that atoms C(1), C(2), C(3), C(4), C(5) and N(1) on the new pyridine ring are slightly distorted, forming a distorted boat conformation. The title compound exo-4-(3,4-dichlorophenyl)-8-ethyl-3,3a,4,5,8,12d-hexahydro-2H-furo[3,2-c]indolo[3,2-f]quinoline (C25H22Cl2N2O, Mr = 437.35) was synthesized and crystallized. The crystal belongs to tetragonal, space group I4(1)/a with a = 17.4903(3), b = 17.4903(3), c = 28.3403(5) , Z = 16, V = 8669.6(3) 3, Dc = 1.340 g·cm-3, μ(MoKɑ) = 0.319 mm-1, F(000) = 3648, R = 0.0429 and wR = 0.711 for 2714 observed reflections I 2σ(I). X-ray analysis reveals that atoms C(1), C(2), C(3), C(4), C(5) and N(1) on the new pyridine ring are slightly distorted, forming a distorted boat conformation.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2011年第9期1275-1278,共4页 结构化学(英文)
基金 supported by the National Natural Science Foundation of China (20802061) Natural Science Foundation of the Education Committee of Jiangsu Province (08KJD150019) Qinglan Project (08QLT001) of the Education Committee of Jiangsu Province
关键词 crystal structure indolo[3 2-f]quinoline NMR crystal structure indolo[3 2-f]quinoline NMR
  • 相关文献

参考文献14

  • 1Cimanga, K.; De Bruyne, T.; Pieters, L.; Claeys, M.; Vlietinck, A. In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta. J. Nat. Prod. 1997, 60, 688-691.
  • 2Sundaram, G. S. M.; Venkatesh, C.; Kumar, U. K. S.; Junjappa, H. I. H. A concise formal synthesis of alkaloid cryptotackiene and substituted 6H-indolo[2,3-b]quinolines. J. Org. Chem. 2004, 69, 5760 -5762.
  • 3Stiborova, M.; Rupertova, M.; Frei, E. Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency. BBA-Proteins Proteom. 2011, 1814, 175-185.
  • 4Huska, D.; Adam, V.; Krizkova, S.; Hrabeta, J.; Eckschlager, T.; Stiborova, M.; Kizek, R. An electrochemical study of interaction of an anticancer alkaloid ellipticine with DNA. CHIM. OGGI 2010, 28, 15-17.
  • 5Mousset, D.; Rabot, R.; Bouyssou, P.; Coudert, G., Gillaizeau, I. Synthesis and biological evaluation of novel benzoxazinic analogues of ellipticine. Tetrahedron Lett. 2010, 51, 3987-3990.
  • 6Gaddam, V.; Ramesh, S.; Nagarajan, R. CuI/La(OTf)3 catalyzed, one-pot synthesis of isomeric ellipticine derivatives in ionic liquid. Tetrahedron 2010, 66, 4218-4222.
  • 7Ergun, Y.; Guile, S.; Bilici, A. C.; Gocmenturk, M.; Okay, G. Synthesis of tricyclic derivatives of antitumor alkaloid ellipticine. Asian .J Chem. 2010, 22, 1853-1858.
  • 8Peczynska-Czoch, W.; Pognan, F.; Kaczmarek, L.; Boratynski, J. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: Novel cytotoxic, DNA topoisomerase II inhibitors. J. Med. Chem. 1994, 37, 3503-3510.
  • 9Kaczmarek, L.; Balicki, R.; Nantka-Narnirski, p.; Peczynska-Czoch, W.; Mordarski, M. Cancerostatics, VI. Synthesis and antineoplastic properties of some benzo-iso-a-carbolines. Arch. Pharm. 1988, 321,463-467.
  • 10Stiborova, M.; Bieler, C. A.; Wiessler, M.; Frei, E. The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. Biochem. Pharmacol. 2001, 62, 1675-1684.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部